ema glp-1 vision loss recommendation november 2025 Wegovy Lawsuit [2026 Update] The science of safety: adverse

Additionally, incretin therapies can have overbearing negative side effects including hypoglycaemia (often in combination with other glucose-lowering treatments), nausea, vomiting, gastrointestinal upset (including diarrhoea) and injection site reactions that contribute to therapy discontinuation ( TABLE 1 Incretin therapy studies including percentage of participants who failed to reach the desired endpoint

J Onco Targets Ther

Jiang T, Ghosh R, Charcosset C

Pre-loading injects is good practice, helps evaluate dosage received/planned

Although contrary to the notion that G6PD-d largely limits proliferative capacity, Varghese et al